Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases
Authors:
- Francesco CasuscelliFCFrancesco Casuscelli
- Elena ArdiniEAElena Ardini
- Nilla AvanziNANilla Avanzi
- Elena CasaleECElena Casale
- Giovanni CerviGCGiovanni Cervi
- Matteo D’aNelloMDMatteo D’aNello
- Daniele DonatiDDDaniele Donati
- Daniela FaiardiDFDaniela Faiardi
- Ronald D. FergusonRFRonald D. Ferguson
- Gianpaolo FogliattoGFGianpaolo Fogliatto
- Arturo GalvaniAGArturo Galvani
- Aurelio MarsiglioAMAurelio Marsiglio
- 1 December 2013
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 21 (23) , 7364-7380
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Pim kinases in cancer: Diagnostic, prognostic and treatment opportunitiesBiochemical Pharmacology, 2013
- Abnormal hematopoietic phenotypes in Pim kinase triple knockout miceJournal of Hematology & Oncology, 2013
- Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer TherapyJournal of Medicinal Chemistry, 2012
- PIM1 kinase as a target for cancer therapyExpert Opinion on Investigational Drugs, 2012
- The oncogenic PIM kinase family regulates drug resistance through multiple mechanismsDrug Resistance Updates, 2011
- For better or for worse: the role of Pim oncogenes in tumorigenesisNature Reviews Cancer, 2010
- PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancersHaematologica, 2010
- Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinomaOncogene, 2010
- Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth FactorsMolecular and Cellular Biology, 2004
- Pim-1: A serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesisJournal of Veterinary Science, 2001